MoHAP Issues Urgent Warning Over Counterfeit Botox Products in UAE

The UAE Ministry of Health and Prevention (MoHAP) has issued an urgent health alert regarding the circulation of counterfeit Botox products within the country. The ministry warned healthcare providers and the public to exercise extreme caution, noting that these falsified medical products pose significant risks to patient safety and public health. Risks of Falsified Medical Products The health authority stated that counterfeit botulinum toxin injections often bypass regulated supply chains and lack the necessary quality controls. Using these unverified products can lead to severe medical complications, including localized paralysis, infections, and systemic toxicity due to inconsistent dosing or the presence of contaminants. MoHAP emphasized that legitimate Botox must be sourced exclusively through authorized distributors and registered with national health registries. Verification Requirements for Clinics Licensed medical facilities and practitioners are instructed to rigorously inspect all aesthetic products before administration. Authorities highlighted that discrepancies in packaging, such as altered font styles, incorrect batch numbers, or the absence of official hologram…